Huntington National Bank Dexcom Inc Transaction History

Huntington National Bank

$12.7 Billion
Q2 2024

A detailed history of Huntington National Bank transactions in Dexcom Inc stock. As of the latest transaction made, Huntington National Bank holds 1,613 shares of DXCM stock, worth $108,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,613

Previous 3,233 50.11%

Holding current value

$108,522

Previous $448,000 59.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $178,702 - $227,528	-1,620 Reduced 50.11%	1,613 $182,000
Q1 2024 May 03, 2024	BUY	$114.22 - $140.1 $253,796 - $311,302	2,222 Added 219.78%	3,233 $448,000
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $11,927 - $19,617	-158 Reduced 13.52%	1,011 $125,000
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $1,463 - $2,344	17 Added 1.48%	1,169 $109,000
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $56,122 - $65,359	499 Added 76.42%	1,152 $148,000
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $6,344 - $7,498	61 Added 10.3%	653 $75,000
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $12,237 - $17,664	144 Added 32.14%	592 $67,000
Q3 2022 Nov 07, 2022	SELL	$76.35 - $94.18 $7,405 - $9,135	-97 Reduced 17.8%	448 $36,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $14,821 - $28,970	218 Added 66.67%	545 $41,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $5,080 - $7,030	54 Added 19.78%	327 $168,000
Q4 2021 Jan 21, 2022	BUY	$129.87 - $162.82 $29,610 - $37,122	228 Added 506.67%	273 $146,000
Q3 2021 Oct 28, 2021	SELL	$106.71 - $143.18 $66,693 - $89,487	-625 Reduced 93.28%	45 $25,000
Q2 2021 Jul 30, 2021	BUY	$80.99 - $107.93 $51,023 - $67,995	630 Added 1575.0%	670 $286,000
Q1 2021 Apr 12, 2021	SELL	$84.79 - $104.74 $932 - $1,152	-11 Reduced 21.57%	40 $14,000
Q4 2020 Jan 11, 2021	BUY	$78.0 - $104.5 $234 - $313	3 Added 6.25%	51 $19,000
Q3 2020 Oct 30, 2020	BUY	$95.51 - $112.95 $764 - $903	8 Added 20.0%	48 $19,000
Q2 2020 Jul 30, 2020	SELL	$62.68 - $105.34 $14,792 - $24,860	-236 Reduced 85.51%	40 $16,000
Q1 2020 Apr 27, 2020	SELL	$47.79 - $75.63 $172,474 - $272,948	-3,609 Reduced 92.9%	276 $75,000
Q4 2019 Jan 17, 2020	BUY	$36.62 - $57.29 $7,909 - $12,374	216 Added 5.89%	3,885 $850,000
Q3 2019 Nov 01, 2019	BUY	$35.53 - $43.8 $128,938 - $158,950	3,629 Added 9072.5%	3,669 $548,000
Q2 2018 Jul 19, 2018	BUY	$17.54 - $25.22 $701 - $1,008	40 New	40 $4,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Dexcom Inc Transaction History